Key Insights

Highlights

Treatment Research

2 treatments under study, led by Pomalidomide

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04902443Phase 1Recruiting

Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV

Showing all 1 trials

Research Network

Common Treatments

  • Pomalidomide1
  • Nivolumab1

Active Sponsors

  • National Cancer Institute (NCI)1

Top Investigators

Related Conditions

  • Kaposi Sarcoma1
  • Viral Associated Malignancies1

Activity Timeline